Symrise AG (ETR:SY1)
Germany · Delayed Price · Currency is EUR 71.06
+0.20 (0.28%)
At close: Jan 30, 2026
Symrise AG Revenue
Symrise AG had revenue of 2.55B EUR in the half year ending June 30, 2025, with 5.80% growth. This brings the company's revenue in the last twelve months to 4.99B, up 2.15% year-over-year. In the year 2024, Symrise AG had annual revenue of 5.00B with 5.67% growth.
Revenue (ttm)
4.99B
Revenue Growth
+2.15%
P/S Ratio
1.99
Revenue / Employee
384.08K
Employees
12,984
Market Cap
9.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.00B | 268.33M | 5.67% |
| Dec 31, 2023 | 4.73B | 111.71M | 2.42% |
| Dec 31, 2022 | 4.62B | 792.79M | 20.72% |
| Dec 31, 2021 | 3.83B | 305.24M | 8.67% |
| Dec 31, 2020 | 3.52B | 112.60M | 3.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Brenntag SE | 15.65B |
| Evonik Industries AG | 14.27B |
| Covestro AG | 13.40B |
| LANXESS Aktiengesellschaft | 5.89B |
| Wacker Chemie AG | 5.57B |
| Verbio SE | 1.67B |
| H&R GmbH & Co. KGaA | 1.30B |
| AlzChem Group AG | 576.14M |
Symrise AG News
- 17 days ago - EQS-DD: Symrise AG: Michael Friede, buy - Wallstreet:Online
- 18 days ago - DAX Pares Early Gains; Symrise, Zalando Move Up Sharply - Nasdaq
- 18 days ago - Symrise In Advanced Talks To Sell Terpenes Business; Swedencare Investment Impaired - Finanz Nachrichten
- 18 days ago - Symrise Launches EUR 400 Mln Share Buy-Back Program - Nasdaq
- 18 days ago - EQS-News: Symrise AG Announces Inaugural Share Buy-back Program - Wallstreet:Online
- 18 days ago - EQS-Adhoc: Symrise AG resolves a share buy-back program in the amount of EUR 400 million - Wallstreet:Online
- 18 days ago - Symrise Announces Terpenes Divestment & Non-Cash Impairment on Swedencare Investment - Wallstreet:Online
- 18 days ago - EQS-Adhoc: Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment. - Wallstreet:Online